ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 29 December to 4 January 2026

The 10 most important of the 109 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Ophthalmology · Ophthalmology · 2025-12-29

Systematic review and meta-analysis of 8 RCTs and 8 observational studies: semaglutide was associated with higher NAION risk only in observational diabetes data (26.7 vs 18.9 per 100,000 person-years; HR 1.85); RCTs and weight-loss studies showed no significant increase.

Meta-analysisn = 1,642,452
Liu et al. Rate and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy with Semaglutide Use for Diabetes and Weight Loss: A Systematic Review and Meta-Analysis
Psychiatry · Lancet Psychiatry · 2026-01-01

Network meta-analysis of 76 RCTs (17,379 adults with remitted depression or anxiety): vs abrupt antidepressant stopping, continuation plus psychological support (RR 0.40), continuation (0.51) and slow tapering plus support (0.52) cut relapse; slow tapering alone did not.

Meta-analysisn = 17,379
Zaccoletti et al. Comparison of antidepressant deprescribing strategies in individuals with clinically remitted depression: a systematic review and network meta-analysis

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.